Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
about
Should there be sex-specific criteria for the diagnosis and treatment of heart failure?Effects of spironolactone and losartan on the early neovascularization of acute myocardial infarction.The past, present and future of renin-angiotensin aldosterone system inhibitionCyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male miceEffect of spironolactone on diastolic function in hypertensive left ventricular hypertrophy.Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives.
P2860
Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
@en
type
label
Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
@en
prefLabel
Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
@en
P2860
P1433
P1476
Aldosterone, mineralocorticoid receptor activation, and cardiovascular remodeling.
@en
P2093
Jane A Leopold
P2860
P304
P356
10.1161/CIRCULATIONAHA.111.067918
P407
P577
2011-11-01T00:00:00Z